Sequana Medical NV
SQNMF
$3.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 56.80K | 57.30K | 176.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 56.80K | 57.30K | 176.60K |
| Cost of Revenue | 200.00 | 200.00 | 14.00K | 14.20K | 40.70K |
| Gross Profit | -200.00 | -200.00 | 42.70K | 43.10K | 135.80K |
| SG&A Expenses | 4.41M | 4.55M | 4.75M | 4.80M | 6.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 75.90K | 78.20K | -76.60K | -77.30K | 112.90K |
| Total Operating Expenses | 4.86M | 5.01M | 5.22M | 5.27M | 7.75M |
| Operating Income | -4.86M | -5.01M | -5.16M | -5.21M | -7.58M |
| Income Before Tax | -17.82M | -18.38M | -5.88M | -5.94M | -8.55M |
| Income Tax Expenses | 71.80K | 74.10K | 78.40K | 79.00K | 113.30K |
| Earnings from Continuing Operations | -17.89M | -18.46M | -5.96M | -6.01M | -8.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.89M | -18.46M | -5.96M | -6.01M | -8.67M |
| EBIT | -4.86M | -5.01M | -5.16M | -5.21M | -7.58M |
| EBITDA | -4.77M | -4.92M | -5.09M | -5.13M | -7.46M |
| EPS Basic | -0.43 | -0.45 | -0.18 | -0.19 | -0.31 |
| Normalized Basic EPS | -0.27 | -0.28 | -0.11 | -0.11 | -0.19 |
| EPS Diluted | -0.43 | -0.45 | -0.18 | -0.19 | -0.31 |
| Normalized Diluted EPS | -0.27 | -0.28 | -0.11 | -0.11 | -0.19 |
| Average Basic Shares Outstanding | 41.15M | 41.15M | 32.35M | 32.35M | 28.24M |
| Average Diluted Shares Outstanding | 41.15M | 41.15M | 32.35M | 32.35M | 28.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |